|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
WO1999023107A1
(en)
|
1997-10-31 |
1999-05-14 |
Maxygen, Incorporated |
Modification of virus tropism and host range by viral genome shuffling
|
|
AU780231B2
(en)
|
1998-11-10 |
2005-03-10 |
University Of North Carolina At Chapel Hill, The |
Virus vectors and methods of making and administering the same
|
|
EP1026250A1
(en)
|
1998-12-02 |
2000-08-09 |
Aventis Behring GmbH |
DNA-constructs of blood clotting factors and P-selectin
|
|
EP1010762A1
(en)
|
1998-12-02 |
2000-06-21 |
Aventis Behring Gesellschaft mit beschränkter Haftung |
DNA constructs of blood clotting factors and P-Selectin
|
|
EP1048726B1
(en)
|
1999-04-27 |
2006-07-26 |
Négrier, Claude |
Modified factor VIII cDNA
|
|
EP1038959A1
(en)
|
1999-03-17 |
2000-09-27 |
Aventis Behring Gesellschaft mit beschränkter Haftung |
Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX
|
|
WO2001068888A2
(en)
|
2000-03-14 |
2001-09-20 |
Neurologix, Inc. |
Production of chimeric capsid vectors
|
|
US7749492B2
(en)
|
2001-01-05 |
2010-07-06 |
Nationwide Children's Hospital, Inc. |
AAV vectors and methods
|
|
AU2002248297A1
(en)
|
2001-01-05 |
2002-07-16 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
IL161827A0
(en)
|
2001-11-13 |
2005-11-20 |
Univ Pennsylvania |
A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novelsequences identified thereby
|
|
CA2469785C
(en)
|
2001-12-17 |
2014-04-22 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
|
|
WO2003092594A2
(en)
|
2002-04-30 |
2003-11-13 |
Duke University |
Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
|
|
DK2657247T3
(en)
|
2003-06-19 |
2017-07-10 |
Genzyme Corp |
AAV virions with reduced immunoreactivity and applications thereof
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
EP3211085B1
(en)
|
2003-09-30 |
2021-03-31 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
|
|
US20060166363A1
(en)
|
2004-01-27 |
2006-07-27 |
Sergei Zolotukhin |
Modified baculovirus expression system for production of pseudotyped rAAV vector
|
|
AU2005316476A1
(en)
|
2004-12-15 |
2006-06-22 |
University Of Florida Research Foundation, Inc. |
Chimeric vectors
|
|
WO2006130639A2
(en)
|
2005-05-31 |
2006-12-07 |
Neurologix, Inc. |
Novel glutamic acid decarboxylase (gad) chimera and methods of use
|
|
US7867484B2
(en)
|
2006-01-27 |
2011-01-11 |
University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
WO2007120542A2
(en)
|
2006-03-30 |
2007-10-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Aav capsid library and aav capsid proteins
|
|
AU2007286807B2
(en)
|
2006-08-21 |
2013-03-21 |
Genentech, Inc. |
Aza-benzothiophenyl compounds and methods of use
|
|
DK2191001T3
(en)
|
2007-04-09 |
2016-09-19 |
Univ Florida |
RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
EP2158211B1
(en)
*
|
2007-05-31 |
2016-08-10 |
Medigene AG |
Mutated structural protein of a parvovirus
|
|
US8632764B2
(en)
|
2008-04-30 |
2014-01-21 |
University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
WO2010093784A2
(en)
|
2009-02-11 |
2010-08-19 |
The University Of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
ES2742180T3
(es)
|
2009-03-04 |
2020-02-13 |
Deutsches Krebsforsch |
Proteína activadora del ensamblaje (AAP) y su uso para la fabricación de partículas de parvovirus que consisten esencialmente en VP3
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
EP2748185A1
(en)
|
2011-08-24 |
2014-07-02 |
The Board of Trustees of The Leland Stanford Junior University |
New aav capsid proteins for nucleic acid transfer
|
|
EP2771455B1
(en)
|
2011-10-28 |
2016-10-05 |
The University of North Carolina At Chapel Hill |
Cell line for production of adeno-associated virus
|
|
EP3738974A1
(en)
|
2012-09-28 |
2020-11-18 |
The University of North Carolina at Chapel Hill |
Aav vectors targeted to oligodendrocytes
|
|
EP2911687B1
(en)
|
2012-10-26 |
2019-02-13 |
Vrije Universiteit Brussel |
Vector for liver-directed gene therapy of hemophilia and methods and use thereof
|
|
WO2014159546A1
(en)
|
2013-03-14 |
2014-10-02 |
Asklepios Biopharmaceutical, Inc. |
Modified soluble vegf receptor-1 genes and vectors for gene therapy
|
|
CN110885854A
(zh)
|
2013-03-15 |
2020-03-17 |
北卡罗来纳-查佩尔山大学 |
双重聚糖结合aav载体的方法和组合物
|
|
CA2917018A1
(en)
|
2013-05-21 |
2014-12-04 |
University Of Florida Research Foundation, Inc. |
Capsid-modified, raav3 vector compositions and methods of use in gene therapy of human liver cancer
|
|
HUE047996T2
(hu)
|
2013-07-22 |
2020-05-28 |
Childrens Hospital Philadelphia |
AAV variáns és készítmények, eljárások és alkalmazások sejtekbe, szervekbe és szövetekbe történõ géntranszferhez
|
|
SI3702466T1
(sl)
|
2013-08-27 |
2023-04-28 |
Research Institute At Nationwide Children's Hospital |
Proizvodi in postopki za zdravljenje amiotrofične lateralne skleroze
|
|
EP3459965B1
(en)
*
|
2013-10-11 |
2020-12-02 |
Massachusetts Eye & Ear Infirmary |
Methods of predicting ancestral virus sequences and uses thereof
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
WO2015126972A1
(en)
|
2014-02-21 |
2015-08-27 |
University Of Florida Research Foundation, Inc. |
Methods and compositions for gene delivery to on bipolar cells
|
|
EP3113787B1
(en)
|
2014-03-04 |
2019-12-04 |
University of Florida Research Foundation, Inc. |
Improved raav vectors and methods for transduction of photoreceptors and rpe cells
|
|
ES2744565T3
(es)
|
2014-04-25 |
2020-02-25 |
Genethon |
Tratamiento de la hiperbilirrubinemia
|
|
EA034355B1
(ru)
|
2014-05-02 |
2020-01-30 |
Джензим Корпорейшн |
Векторы на основе aav для генной терапии в сетчатке и cns
|
|
EP3151866B1
(en)
|
2014-06-09 |
2023-03-08 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
CN107073051B
(zh)
|
2014-10-21 |
2021-08-24 |
马萨诸塞大学 |
重组aav变体及其用途
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
EP4344741A3
(en)
|
2014-11-21 |
2024-08-28 |
The University of North Carolina at Chapel Hill |
Aav vectors targeted to the central nervous system
|
|
GB201502137D0
(en)
|
2015-02-09 |
2015-03-25 |
Ucl Business Plc |
Treatment
|
|
US10648000B2
(en)
|
2015-02-16 |
2020-05-12 |
University Of Florida Research Foundation, Incorporated |
rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes
|
|
US20180245073A1
(en)
|
2015-02-23 |
2018-08-30 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
US11021519B2
(en)
|
2015-03-02 |
2021-06-01 |
Adverum Biotechnologies, Inc. |
Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
|
|
EP3277819B1
(en)
|
2015-03-24 |
2021-03-03 |
The Regents of The University of California |
Adeno-associated virus variants and methods of use thereof
|
|
US10081659B2
(en)
|
2015-04-06 |
2018-09-25 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Adeno-associated vectors for enhanced transduction and reduced immunogenicity
|
|
WO2016172155A1
(en)
|
2015-04-23 |
2016-10-27 |
University Of Massachusetts |
Modulation of aav vector transgene expression
|
|
GB201508026D0
(en)
*
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
IL256517B2
(en)
|
2015-06-23 |
2024-06-01 |
Childrens Hospital Philadelphia |
Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
|
|
US20180216133A1
(en)
|
2015-07-17 |
2018-08-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for achieving high levels of transduction in human liver cells
|
|
WO2017023724A1
(en)
|
2015-07-31 |
2017-02-09 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of aadc deficiency
|
|
AU2016332821B2
(en)
|
2015-09-28 |
2022-02-17 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for antibody-evading virus vectors
|
|
WO2017066764A2
(en)
|
2015-10-16 |
2017-04-20 |
William Marsh Rice University |
Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
|
|
EP3368054A4
(en)
|
2015-10-28 |
2019-07-03 |
Voyager Therapeutics, Inc. |
REGULATORY EXPRESSION USING THE ADENO-ASSOCIATED VIRUS (AAV)
|
|
HK1258413A1
(zh)
|
2015-10-29 |
2019-11-08 |
Voyager Therapeutics, Inc. |
遞送中樞神經系統(cns)靶向多核苷酸
|
|
PE20231949A1
(es)
|
2015-10-30 |
2023-12-05 |
Spark Therapeutics Inc |
VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA
|
|
JP6767483B2
(ja)
|
2015-11-05 |
2020-10-14 |
バンブー セラペウティクス インク |
遺伝子療法のための、改変されたフリードライヒ運動失調症遺伝子およびベクター
|
|
US10406244B2
(en)
|
2015-12-02 |
2019-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
AAV vectors with expanded packaging capacity
|
|
EP3384034B1
(en)
|
2015-12-02 |
2020-07-08 |
The Board of Trustees of the Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
|
|
WO2017100671A1
(en)
|
2015-12-11 |
2017-06-15 |
California Institute Of Technology |
TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs)
|
|
AU2016371779C1
(en)
|
2015-12-14 |
2022-10-13 |
The University Of North Carolina At Chapel Hill |
Modified capsid proteins for enhanced delivery of parvovirus vectors
|
|
WO2017143100A1
(en)
|
2016-02-16 |
2017-08-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
|
|
CA3018076A1
(en)
|
2016-03-18 |
2017-09-21 |
The Children's Hospital Of Philadelphia |
Therapeutic for treatment of diseases including the central nervous system
|
|
US11433116B2
(en)
|
2016-04-14 |
2022-09-06 |
Cedars-Sinai Medical Center |
GJA1 isoforms protect against metabolic stress
|
|
WO2017189963A1
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
EP3458588B1
(en)
|
2016-05-18 |
2025-10-29 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
US20210108225A1
(en)
|
2016-06-16 |
2021-04-15 |
Charite - Universitatsmedizin Berlin |
Neuropeptide-expressing vectors and methods for the treatment of epilepsy
|
|
IL305149A
(en)
|
2016-07-26 |
2023-10-01 |
Biomarin Pharm Inc |
Novel adeno-associated virus capsid proteins
|
|
US11698377B2
(en)
|
2016-08-15 |
2023-07-11 |
Genzyme Corporation |
Methods for detecting AAV
|
|
CA3035628A1
(en)
|
2016-09-02 |
2018-03-08 |
Spark Therapeutics, Inc. |
Methods and vectors for treating cns disorders
|
|
EP3293203A1
(en)
|
2016-09-12 |
2018-03-14 |
Genethon |
Acid-alpha glucosidase variants and uses thereof
|
|
EP3293259A1
(en)
|
2016-09-12 |
2018-03-14 |
Genethon |
Acid-alpha glucosidase variants and uses thereof
|
|
AU2017322376B2
(en)
|
2016-09-12 |
2023-08-17 |
Association Institut De Myologie |
Acid-alpha glucosidase variants and uses thereof
|
|
KR20190075964A
(ko)
|
2016-10-13 |
2019-07-01 |
유니버시티 오브 매사추세츠 |
Aav 캡시드 설계
|
|
GB2607227B
(en)
|
2016-10-27 |
2023-05-10 |
Intima Bioscience Inc |
Viral methods of T cell therapy
|
|
CA3052829A1
(en)
|
2017-02-15 |
2018-08-23 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for gene transfer across the vasculature
|
|
CA3053455A1
(en)
|
2017-03-10 |
2018-09-13 |
Genethon |
Treatment of glycogen storage disease iii
|
|
EP3610023B1
(en)
|
2017-03-15 |
2023-10-04 |
The University of North Carolina at Chapel Hill |
Polyploid adeno-associated virus vectors and methods of making and using the same
|
|
EP4219806A3
(en)
|
2017-04-11 |
2023-09-27 |
Ruprecht-Karls-Universität Heidelberg |
Adeno-associated virus library
|
|
WO2018200419A1
(en)
|
2017-04-23 |
2018-11-01 |
The Trustees Of The University Of Pennsylvania |
Viral vectors comprising engineered aav capsids and compositions containing the same
|
|
CN111108198A
(zh)
|
2017-05-05 |
2020-05-05 |
沃雅戈治疗公司 |
治疗亨廷顿病的组合物和方法
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
SG11201911603SA
(en)
|
2017-06-07 |
2020-01-30 |
Spark Therapeutics Inc |
ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
MY207534A
(en)
|
2017-06-30 |
2025-03-03 |
Spark Therapeutics Inc |
Aav vector column purification methods
|
|
KR20200036912A
(ko)
|
2017-07-31 |
2020-04-07 |
리플렉션 바이오테크놀러지스 리미티드 |
안과 질환을 위한 세포 모델 및 치료요법
|
|
SG11202000650YA
(en)
|
2017-08-01 |
2020-02-27 |
Spark Therapeutics Inc |
Factor viii (fviii) gene therapy methods
|
|
TWI832036B
(zh)
|
2017-08-03 |
2024-02-11 |
美商航海家醫療公司 |
用於aav之遞送之組合物及方法
|
|
WO2019043081A1
(en)
|
2017-08-29 |
2019-03-07 |
Ruprecht-Karls-Universität Heidelberg |
RATIONALLY DESIGNED PSEUDOVIRAL PARTICLES FOR THE MODULATION OF CHIMERIC ANTIGENIC RECEPTOR (CAR) T CELL THERAPY
|
|
WO2019060649A1
(en)
|
2017-09-22 |
2019-03-28 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
|
|
WO2019073059A1
(en)
|
2017-10-12 |
2019-04-18 |
Freeline Therapeutics Limited |
ADENOVIRAL AUXILIARY VIRUSES WITH DEFECTIVE CYCLE LIFE, PRODUCTION AND USE FOR THE PRODUCTION OF RAAV
|